Navigation Links
MD Anderson study finds qigong improves quality of life for breast cancer patients
Date:1/25/2013

HOUSTON - Researchers from The University of Texas MD Anderson Cancer Center have found qigong, an ancient mind-body practice, reduces depressive symptoms and improves quality of life in women undergoing radiotherapy for breast cancer.

The study, published in the journal Cancer, is the first to examine qigong in patients actively receiving radiation therapy and include a follow-up period to assess benefits over time. Even though individual mind-body practices such as meditation and guided imagery appear to reduce aspects of distress and improve quality of life, questions remain about their effectiveness when conducted in conjunction with radiation therapy.

"We were also particularly interested to see if qigong would benefit patients experiencing depressive symptoms at the start of treatment," said Lorenzo Cohen, Ph.D., professor in MD Anderson's Departments of General Oncology and Behavioral Science and director of the Integrative Medicine Program. "It is important for cancer patients to manage stress because it can have a profoundly negative effect on biological systems and inflammatory profiles."

For the trial, Cohen, the corresponding author, and his colleagues enrolled 96 women with stage 1-3 breast cancer from Fudan University Shanghai Cancer Center in Shanghai, China. Forty-nine patients were randomized to a qigong group consisting of five 40-minute classes each week during their five-to-six week course of radiation therapy, while 47 women comprised a waitlist control group receiving the standard of care.

The program incorporated a modified version of Chinese medical qigong consisting of synchronizing one's breath with various exercises. As a practice, qigong dates back more than 4,000 years when it was used across Asia to support spiritual health and prevent disease.

Participants in both groups completed assessments at the beginning, middle and end of radiation therapy and then one and three month
'/>"/>

Contact: William Fitzgerald
wbfitzgerald@mdanderson.org
713-792-9518
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

0

GOOD

Page: 1 2 3

Related medicine news :

1. UT MD Anderson scientists find protein that reins in runaway network
2. UT MD Anderson, GlaxoSmithKline to collaborate on new approach to cancer immune therapy
3. Horner Flooring to provide court for the MD Anderson Proton Therapy Showcase in Houston.
4. UT MD Anderson study finds link between statins and improved survival in inflammatory breast cancer
5. UT MD Anderson Cancer Center launches unprecedented Moon Shots Program
6. UT MD Anderson study finds link between depressive symptoms and cancer survival
7. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
8. University of Houston Graduate College of Social Work announces partnership with MD Anderson
9. UT MD Anderson study finds cancer related pain often undertreated
10. UK study shows abuse may affect cancer-related well-being in female patients
11. Very Obese Teens See Heart Gains From Weight-Loss Surgery: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MD Anderson study finds qigong improves quality of life for breast cancer patients
(Date:6/18/2013)... June 19, 2013 Looking for a way ... of everyday life? , IWALKAWAKE is a guide to ... by Adam Botha, it focuses on harnessing the powerful and ... book lays out a nine-step guide to finding one’s true ... a person must go through to reach their true potential. ...
(Date:6/18/2013)... 2013 The Drug Delivery Partnering Terms ... to the drug delivery partnering deals and agreements entered ... The report provides a detailed understanding and analysis of ... The majority of deals are discovery or development stage ... right to license the license drug delivery technology. These ...
(Date:6/18/2013)... 18, 2013 Palo Alto has taken yet ... greenest cities with its recent major long-term solar power commitment. ... major solar electric power purchase agreements , which together will ... of solar photovoltaic electric power per year, which is the ... That’s enough power to supply all 65,000+ Palo Alto ...
(Date:6/18/2013)... research has shown that cancer cells have a much ... cells. Now, scientists at The University of Texas at ... a new strategy to combat lung cancer. , In ... PLOS ONE , UT Dallas researchers compared the ... lung cells taken from the same patient. , ...
(Date:6/18/2013)... Los Angeles, CA (PRWEB) June 18, 2013 ... article entitled “The Cheater’s Guide to Getting Beach Ready,” offers ... women ready to look their best in a bathing suit ... marks , skin firming , smoothing cellulite , ... says Dr. Simon Ourian, Medical Director of Epione Beverly Hills, ...
Breaking Medicine News(10 mins):Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Skin Care – Getting Your Body Beach Ready 2
... as you get older, then a research team from the ... South West of England may have good news for you. ... are effective at reversing age-related deficits in memory, according to ... Free Radical Biology and Medicine. The researchers working at ...
... Six Awardees Honored for Achievement in Multidisciplinary Pain ... Specialty Programs in Occupational Health and Pediatrics, ... Pain Society,(APS), http://www.ampainsoc.org, today announced the ... in Pain Management Awards,recognizing the nation,s outstanding pain ...
... 10 Merit Medical,Systems, Inc. (Nasdaq: MMSI ), ... primarily in cardiology and radiology,procedures, announced today that the ... ended March 31, 2008, after the close of the,stock ... hold its investor conference call on the same day ...
... Sheets:,HEII; http://www.heii.com ) today announced its financial results ... March 1, 2008., Net sales for the second ... of fiscal year 2007. The Company,generated a net loss ... compared to a net loss of ($1,571,000) for the ...
... 2008 According to a study published in The ... from the Stenting and Angioplasty with Protection in Patients ... with severe blocked carotid arteries, the main blood vessels ... carotid artery stenting (CAS) with the PRECISE Nitinol Stent ...
... Institute,s Power of Impressions Conference Reveals ... Behind Healthcare Trends, DALLAS, April 10 Consumers ... organizations to take a,new approach to service delivery, employee ... by nearly 20 speakers at The Beryl,Institute,s "Power of ...
Cached Medicine News:Health News:Getting forgetful? Then blueberries may hold the key 2Health News:American Pain Society Announces Recipients of Clinical Centers of Excellence in Pain Management Awards 2Health News:American Pain Society Announces Recipients of Clinical Centers of Excellence in Pain Management Awards 3Health News:Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the First Quarter Ended March 31, 2008 2Health News:Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the First Quarter Ended March 31, 2008 3Health News:HEI, Inc. Announces Results for the Second Quarter Fiscal 2008 2Health News:HEI, Inc. Announces Results for the Second Quarter Fiscal 2008 3Health News:HEI, Inc. Announces Results for the Second Quarter Fiscal 2008 4Health News:HEI, Inc. Announces Results for the Second Quarter Fiscal 2008 5Health News:NEJM study demonstrates carotid stenting with embolic protection is comparable to surgery 2Health News:Consumerism Driving Healthcare Change 2
(Date:6/18/2013)... and NEW YORK , June ... Company) (NYSE: BDX ) are accelerating the development ... glucose sensing technologies through a new collaboration announced today. This ... focused on type 1 diabetes (T1D). Many patients ... pump – requiring a catheter to be placed in the ...
(Date:6/18/2013)... EMERYVILLE, Calif. , June 18, 2013 ... today from a Phase 2/3 clinical trial of ... statistically significant improvement in levodopa-induced dyskinesia (LID) as ... versus placebo in the Unified Dyskinesia Rating Scale ... amantadine intended for once-nightly administration that is being ...
(Date:6/17/2013)... June 17, 2013 Velplex, LLC announced this ... technology platform that connects buyers and sellers of ... industry leader. Why? It,s because the ... intimately familiar with the dental industry. They have 50 ... have diligently worked to negotiate some of the best ...
Breaking Medicine Technology:JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6TopProdeals.com Rises to Top as Discount Dental Supply Leader 2
... N.J., Nov. 3, 2011 Savient Pharmaceuticals, Inc. (NASDAQ: ... and nine months ended September 30, 2011, which reflect the ... Savient ended the quarter with $202.7 million in cash and ...  For the third quarter of 2011, the Company had a ...
... of Pharmaceutical and Biotech Trainers ( SPBT ) today announced ... Board of Directors, effective January 1, 2012.  She brings to ... management development, sales, and marketing. A valuable SPBT ... president of the SPBT Board since 2006.  In her new ...
Cached Medicine Technology:Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 2Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 3Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 4Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 5Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 6Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 7Carol Wells Elected President of the Society of Pharmaceutical and Biotech Trainers 2
... display and IOL power calculation software. ... firmware module with SRKII, SRKT, Holladay Dioptimum ... increase in frequency the closer you get ... is achieved with corneal indentation. Triple tone ...
The CryoSurgery console is the control center for CryoCath's surgical probe. It is a modular system made up of a console control unit and a tank dolly system. The system can be used as a unit or in s...
... SurgiFrost is a malleable, single-use cryosurgical probe ... surgery. The probe will ablate cardiac tissue ... cardiac surgical procedure, such as coronary artery ... replacement and/or repair and as part of ...
The Medtronic CardioRhythm Marinr Catheter is intended for use in diagnostic electrophysiologic procedures. These catheters are designed for recording intracardiac electrograms and temporary pacing a...
Medicine Products: